Drug-induced liver injury is categorized as hepatocellular when AST and ALT elevations predominate, or cholestatic when alkaline phosphatase elevation predominates

Overview Debates Related claims Topics

Generation of reactive metabolites during medication metabolism is a compound-specific risk factor for liver toxicity

Intrinsic drug-induced liver injury is dose-dependent and predictable

Idiosyncratic drug-induced liver injury is unpredictable and generally not related to dose

Clinical worsening, progressive biochemical deterioration, or diagnostic uncertainty warrants referral to a gastroenterologist or hepatologist

Susceptibility to idiosyncratic drug-induced liver injury has a genetic component

Drug-induced liver injury is broadly classified into intrinsic and idiosyncratic forms

The presence of jaundice in suspected drug-induced liver injury is an indication for gastroenterology or hepatology referral

Animal models exist to study intrinsic drug-induced liver injury

Epidemiological data estimates the incidence of idiosyncratic drug-induced liver injury at approximately 20 cases per 100,000 person-years

Practice guidelines recommend a routine right upper quadrant ultrasound during the evaluation of suspected drug-induced liver injury

Hepatic metabolism of a compound by cytochrome P450 enzymes is a risk factor for liver injury

Serum bilirubin elevation, rather than the absolute level of aminotransferases, is the primary determinant of severe outcomes in drug-induced liver injury

Severe drug-induced liver injury can cause symptoms including right upper quadrant pain, pruritus, fatigue, nausea, and vomiting

Patients with drug-induced liver injury and severe jaundice require liver biochemistry monitoring every two to three days

Patients with underlying liver disease face a three- to four-fold higher risk of poor outcomes from drug-induced liver injury compared to patients without liver disease

Cirrhosis confers a higher risk of adverse outcomes from drug-induced liver injury than chronic hepatitis

Idiosyncratic drug-induced liver injury is a diagnosis of exclusion without a definitive gold-standard test

The human gut microbiome contains more individual Escherichia coli bacteria than the total count of human beings who have ever lived

Richard Socher's concept of a Eureka Machine envisions AI systems that autonomously generate ideas, run experiments, and validate discoveries across scientific disciplines

Parallel Bio develops human organoids from pluripotent stem cells derived from human blood or skin cells